HARROW, INC. — Director's Dealing 2008

Apr 28, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-04-24

Reporting Person: Lomoro John T (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-04-24	Employee Stock Option (right to buy)	$2.00	A	100000	Acquired	2018-04-23	Common Stock (100000)	Direct

Footnotes

F1: The options vest one-twelfth per quarter commencing on the first full quarter after the initial grant date of April 24, 2008.